Featured Image of Top News Story: Researchers study young cancer survivors and their opioid use.

Researchers study young cancer survivors and their opioid use.

Young cancer survivors were more likely to be on long-term opioid therapy when compared to their counterparts without cancer. But among those on long-term opioid therapy, young cancer survivors were less likely to develop opioid use disorder than their peers without cancer, according to Kaiser Permanente ...

  • Interns make incredible contributions to research

    September 15, 2023
      When Cheyne Hoke began in the Department of Research & Evaluation’s internship program in June 2023, she was a University of California, Berkeley MPH candidate focused on epidemiology and biostatistics. As an intern she spent her summer months working remotely with Kaiser Permanente researchers on what some might consider a “geeky” endeavor: SAS EG extracting, ...
    Read more...
  • Unveiling the Impact: Kaiser Permanente’s Annual Report 2022

    August 2, 2023
    As we journeyed through 2022, the shadow of COVID-19 continued to loom large, with new variants creating new challenges. Yet, in the face of this, Kaiser Permanente Southern California remained steadfast in its commitment to research and discovery, both in researching COVID-19, but also addressing other health burdens faced by our Kaiser Permanente members including ...
    Read more...
  • Research helps determine what isn’t really helping

    July 19, 2023
    Back in 1991, the American Academy of Pediatrics began recommending testing preterm infants before they left the hospital to check that their breathing ability was mature enough when in a car seat to be discharged safely. At the time, there were no studies that showed whether this screening — which takes 2 hours of NICU ...
    Read more...
  • Kaiser Permanente colon cancer patients fare better

    June 12, 2023
    Kaiser Permanente Southern California members with colon cancer had a lower risk of premature death compared to insured patients diagnosed in other hospitals in Southern California, according to a study published this month in The American Surgeon. This benefit was most pronounced among people who were in the lowest socioeconomic group. Unlike the insured patients ...
    Read more...
  • Five questions for … Dr. Michael Aragones

    April 24, 2023
    Kaiser Permanente Southern California has 2 Regional Reference Laboratories, which make up a sophisticated clinical laboratory management system that interfaces with medical centers and medical offices throughout the region. Michael Aragones, MD, is a Research & Evaluation research lab project manager at the Sherman Way and Chino Hills regional laboratories, which share responsibility for testing ...
    Read more...
  • Increasing vaccine equity in Southern California

    March 29, 2023
    In addition to bringing isolation and illness to the world, the COVID-19 pandemic spotlighted the health disparities between Southern California communities. Getting COVID-19 vaccines to the neighborhoods where they were most needed was one of the greatest challenges health care providers experienced during the pandemic. At Kaiser Permanente in Southern California, people rallied to address the ...
    Read more...
  • Atrial fibrillation may increase risk for dementia

    March 27, 2023
    People who have been diagnosed with atrial fibrillation are known to have an increased risk of developing other heart problems. A new Kaiser Permanente study suggests they may also be at increased risk for dementia. The researchers found that people with atrial fibrillation, the most common type of irregular heartbeat, had a 13% greater risk of ...
    Read more...
  • Five questions for … Dr. Bechien Wu

    March 27, 2023
    Dr. Bechien Wu is a gastroenterologist  at the Kaiser Permanente Los Angeles Medical Center and chair of the Southern California Permanente Medical Group Regional Research Committee. He was recently appointed to be the physician director of Clinician Research. In his new role, Dr. Wu will provide scientific leadership to the new Division of Clinician Research within ...
    Read more...
  • Paxlovid associated with lower risk of hospital admission

    March 16, 2023
    A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity or age. The study was published March 15, 2023, in The Lancet Infectious Diseases. “Among Kaiser Permanente members in Southern California who tested positive for ...
    Read more...
  • Extra pounds put kids at higher risk for hypertension

    March 14, 2023
    A study of more than 800,000 young people between the ages of 3 and 17 showed that youth at the upper range of average  weight had a 26% higher risk of developing hypertension than those closer to what is considered average weight. The study was published March 14, 2023, in JAMA Network Open. “Hypertension during youth ...
    Read more...